Treatment Progress for EGFR Wild-type Advanced Non-small Cell Lung Cancer

Treatment Progress for EGFR Wild-type Advanced Non-small Cell Lung Cancer

Lung cancer is the leading cause of death from cancer in the world. The treatment remains one of the most challenging tasks in the medical world. The discovery and development of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) have had a major impact in the treatment of non sma...

Full description

Bibliographic Details
Main Authors:	Feng MA, Xiaoyu SHI, Wei MENG, Jing ZHANG, Lixia ZHAO, Xiaohua HE, Junfeng ZHAO
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-07-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms Epidermal growth factor receptor Wild type Chemotherapy Targeted therapy Maintenance treatment
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2014.07.14

Similar Items

Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
by: Hui ZHANG, et al.
Published: (2017-01-01)

Research Progression of Maintenance Therapy in Small Cell Lung Cancer
by: Yunyun LU, et al.
Published: (2015-09-01)

Progress in Treatment of Advanced Squamous Cell Lung Cancer
by: Ming GAO, et al.
Published: (2020-10-01)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01)

Improving Outcomes in Advanced Lung Cancer : Maintenance therapy in non-small-cell lung carcinoma
by: Muhammad Furrukh, et al.
Published: (2013-02-01)

Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study
by: Minami S, et al.
Published: (2017-02-01)

Treatment of Advanced Squamous Cell Lung Cancer
by: Yixiang ZHU, et al.
Published: (2016-10-01)

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Sheng YANG, et al.
Published: (2016-05-01)

Advances in the Treatment of Relapsed Small Cell Lung Cancer
by: Bin LIU, et al.
Published: (2017-03-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience
by: Lin L, et al.
Published: (2016-10-01)

Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case Report
by: Genovefa Polychronidou, et al.
Published: (2013-03-01)

Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database
by: Guangsheng ZHU, et al.
Published: (2021-04-01)

Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
by: Fan YANG, et al.
Published: (2011-08-01)

Comparison of EGFR Mutation Status in Paired Pre- and Post-chemotherapy Serum for Advanced Pulmonary Adenocarcinoma
by: Rubing HAN, et al.
Published: (2011-02-01)

Progress in Non-invasive Detection of EGFR Mutation in Non-small Cell Lung Cancer
by: Shiyang YUAN, et al.
Published: (2018-12-01)

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer
by: Wensheng ZHOU, et al.
Published: (2020-02-01)

Clinical Observation of EGFR-TKI as A First-line Therapy on Advanced Non-small Cell Lung Cancer
by: Jianjie LI, et al.
Published: (2012-05-01)

Analysis of the Efficacy of Immunotherapy on the Posterior Lines  of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer
by: Li MA, et al.
Published: (2021-05-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

Recent Advances and Future Strategies for Small Cell Lung Cancer
by: Weipeng SHAO, et al.
Published: (2017-06-01)

Clinical Observation on the Target Therapy of Rh-Endostin, Combined with Chemotherapy in Advanced Non-Small Cell Lung Cancer
by: Yiling FENG, et al.
Published: (2009-07-01)

Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy  in Advanced NSCLC Patients with EGFR Mutations
by: Minjiang CHEN, et al.
Published: (2019-02-01)

Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2018-09-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma
by: Ping HE, et al.
Published: (2013-10-01)

EGFR-dependent Impact of Indol-3-Carbinol on Radiosensitivity  of Lung Cancer Cells
by: Xiao XIAO, et al.
Published: (2012-07-01)

The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
by: Xiangtao YAN, et al.
Published: (2011-03-01)

How to Make the Choice in the Retreatment of EGFR-TKI for Advanced NSCLC Patients Who Benefited from Prior Gefitinib Therapy: the Original Drug or Switching to A Second EGFR-TKI?
by: Chuanhao TANG, et al.
Published: (2013-07-01)

The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis
by: Jie WANG, et al.
Published: (2009-12-01)

Interstitial Lung Disease Associated with Lung Cancer Treatment
by: Zhiwei CAO, et al.
Published: (2013-05-01)

Advances in the Research of Autophagy in EGFR-TKI Treatment and Resistance  in Lung Cancer
by: Qicheng ZHANG, et al.
Published: (2016-09-01)

EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients
by: Li SHAN, et al.
Published: (2013-02-01)

Intercalated Combination of Chemotherapy and EGFR-TKIs versus Chemotherapy Alone in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis
by: Chaoyu HONG, et al.
Published: (2016-12-01)

A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer with Uncommon EGFR Mutations
by: Wenxing DU, et al.
Published: (2019-09-01)

Pemetrexed Combined DDP in the Treatment of Advanced Non-small Cell Lung Cancer: A Case Report and Literature Review
by: Changlin ZHAO, et al.
Published: (2010-07-01)

Detection of EGFR and COX-2 Expression by Immunohistochemical Method on a Tissue Microarray Section in Lung Cancer and Biological Significance
by: Xinyun WANG, et al.
Published: (2010-02-01)

The Question and Analysis about Maintenance Therapy  in Advanced Non-small Cell Lung Cancer
by: Xiaoqing LIU
Published: (2014-04-01)

The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
by: Xuebing LI, et al.
Published: (2008-04-01)

Analysis of the Efficacy and Survival of Third-line Treatment  in Advanced Non-small Cell Lung Cancer
by: Lan SHAO, et al.
Published: (2012-06-01)